Item: Method Health
Rating: 5
Author: Buck Wise

Connecting the Dots on Celiac Disease, Non-Celiac Gluten Sensitivity, and Crohn’s Disease.

In the U.S., 2 in 5 Americans are affected by GI disorders.

This Celiac, IBS, and Crohn’s Array (CICA) evaluates your genetic risk for celiac disease and Crohn’s disease, serum markers associated with an active celiac disease process, and serum markers associated with active Crohn’s disease.

Physician Reviewed Results

Method Health tests are reviewed between you and one of our board-certified physicians—In-person or via telehealth.

We accept HSA/FSA payments

In the United States, an estimated 60-70 million people are affected by gastrointestinal disorders (GI). Celiac disease may be present despite the absence of GI symptoms, particularly, in relatives of individuals with celiac disease.

Who may benefit from this Celiac, IBS, Crohn’s test?

Those with gastrointestinal symptoms and autoimmune disorders that might suggest a problem with gluten
Those with increased intestinal permeability which has been linked to autoimmune disorders and other conditions
Those suspected to have Crohn’s or celiac disease
Those suffering from symptoms of IBS including diarrhea, bloating, or cramping
Those with chronic fatigue
Those with nutrient malabsorption and/or deficiency
Those with unexplained symptoms such as unintended weight loss or skin rash

More Genetic Tests: Alcat Food and Chemical Sensitivity Test | Biological Age (telomere) Test | Celiac, IBS and Crohn’s disease Test | Advanced MethylDetox MTHFR Test